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Abstract 
Wound healing is complex and highly orchestrated. It is well appreciated that leukocytes, particularly 
macrophages, are essential for inducing the formation of new connective tissue, which requires the 
generation of signals that stimulate mesenchymal stem cells (MSC), myofibroblasts and fibroblasts. A 
key role for keratinocytes in this complex process has yet to be established. To this end, we investigated 
possible involvement of keratinocytes in connective tissue healing. By lineage-specific deletion of the 
forkhead box-O 1 (FOXO1) transcription factor, we demonstrate for the first time that keratinocytes 
regulate proliferation of fibroblasts and MSCs, formation of myofibroblasts and production of collagen 
matrix in wound healing. This stimulation is mediated by a FOXO1 induced TGFβ1/CTGF axis. The results 
provide direct evidence that epithelial cells play a key role in stimulating connective tissue healing through 
a FOXO1-dependent mechanism. Thus, FOXO1 and keratinocytes may be an important therapeutic target 
where healing is deficient or compromised by a fibrotic outcome. 
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FOXO1 expression in keratinocytes 
promotes connective tissue healing
Chenying Zhang1,2, Jason Lim2, Jian Liu2,3, Bhaskar Ponugoti2, Sarah Alsadun2, Chen Tian2, 
Rameen Vafa2 & Dana T. Graves2
Wound healing is complex and highly orchestrated. It is well appreciated that leukocytes, particularly 
macrophages, are essential for inducing the formation of new connective tissue, which requires the 
generation of signals that stimulate mesenchymal stem cells (MSC), myofibroblasts and fibroblasts. A 
key role for keratinocytes in this complex process has yet to be established. To this end, we investigated 
possible involvement of keratinocytes in connective tissue healing. By lineage-specific deletion of the 
forkhead box-O 1 (FOXO1) transcription factor, we demonstrate for the first time that keratinocytes 
regulate proliferation of fibroblasts and MSCs, formation of myofibroblasts and production of collagen 
matrix in wound healing. This stimulation is mediated by a FOXO1 induced TGFβ1/CTGF axis. The 
results provide direct evidence that epithelial cells play a key role in stimulating connective tissue 
healing through a FOXO1-dependent mechanism. Thus, FOXO1 and keratinocytes may be an important 
therapeutic target where healing is deficient or compromised by a fibrotic outcome.
Wound healing is complex and highly orchestrated. Normal wound healing is divided into overlapping phases of 
inflammation, cellular proliferation, matrix production and tissue remodeling1. New connective tissue provides 
a supporting bed for the epithelium and restores dermal function. The production of connective tissue matrix is 
carried out by fibroblasts and myofibroblasts that migrate from adjacent tissue or differentiate from mesenchymal 
stem cells (MSCs)2,3. Leukocytes, particularly macrophages are thought to be essential for inducing formation 
of new connective tissue4–6 by generating signals that stimulate MSCs and fibroblasts7. Interestingly, in some 
genetically modified mice and in fetal wounds there is substantially reduced numbers of macrophages without 
impairment of healing8,9, suggesting the existence of as yet unidentified critical mechanisms of wound healing.
Interactions between epidermal keratinocytes and dermal fibroblasts contribute to the organization of the epi-
dermis and are thought to promote early wound healing10. Paracrine cross talk of cytokines between dermal fibro-
blasts and epidermal keratinocytes may play a role in this process11,12. During healing process re-epithelialization 
coincides with the recruitment of MSCs and proliferation of dermal fibroblasts13,14. The expression of growth fac-
tors, extracellular matrix constituents, proteases, and intracellular structural proteins in fibroblasts are modulated 
by keratinocytes when fibroblasts and keratinocytes are co-cultured15. In addition, myofibroblast differentiation is 
increased by co-culture of fibroblasts with keratinocytes16. This is useful to healing since myofibroblasts produce 
extracellular matrix and contract granulation tissue. Taken together these studies provide a framework to suggest 
that keratinocytes may modulate connective tissue healing but direct evidence for this concept is lacking.
We have recently shown that the forkhead box-O 1 (FOXO1) transcription factor plays a critical role in 
re-epithelialization in vitro, while FOXO3, a related FOXO transcription factor, had little to no effect17. FOXO1 
modulates several aspects of keratinocyte behavior including resistance to oxidative stress, keratinocyte migration 
and is also an important regulator of broad gene expression programs, including metabolism (e.g. gluconeogen-
esis, amino acid catabolism, glycolysis, pentose phosphate shunt, and fatty acid/triglyceride/sterol synthesis), 
cell cycle, stress response, and longevity in Caenorhabditis elegans18,19. In this report, we tested the hypothesis 
that epithelial cell-specific FOXO1 is additionally involved in the regulation of connective tissue wound heal-
ing. Specifically, to investigate the role of cutaneous epithelium in connective tissue healing, we examined full 
thickness wounds in mice with keratin-14 driven FOXO1 deletion compared to littermate controls. The results 
demonstrate for the first time that FOXO1 activates epithelial cells to regulate proliferation of fibroblasts and 
MSCs, formation of myofibroblasts and production of collagen matrix. These studies provide a basis to further 
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investigate the impact of epithelium on wound healing, which up to now has focused primarily on the effects of 
macrophages or the effect of connective tissue cells on epithelium. Furthermore, the results solidify the critical 
impact of the transcription factor FOXO1 in modulating the wound healing behavior of keratinocytes.
Results
Keratinocyte-specific deletion of FOXO1 impairs connective tissue healing responses in mice 
dermal wounds. To explore the role of FOXO1 in dermal wound healing, experimental mice with keratino-
cyte-specific FOXO1 deletion (FOXO1 deleted in KC) were compared to littermate controls (wild type). FOXO1 
expression was almost 10 fold higher in the epithelium than connective tissue and reduced in epithelium by more 
than 85% in experimental (p < 0.05) but not control littermates (p < 0.05) (Fig. 1a). We previously demonstrated 
that deleting FOXO1 in keratinocytes impaired re-eppithelialization17. Surprisingly, the effect on connective tis-
sue was similarly important as FOXO1 ablation in keratinocytes significantly reduced connective tissue healing 
(Fig. 1b,c). We examined newly formed granulation tissue and collagen matrix by Masson’s trichrome staining 
4 and 7 days after wounding, time points when granulation tissue formation is robust (day 4) and a later time 
point when granulation tissue is present but the wound is in the process of closing (day 7) (Fig. 1b,c). At 4 days 
keratinocyte-specific deletion of FOXO1 reduced the amount of granulation tissue by 44% and on day 7 by 40% 
compared to littermate control mice (p < 0.05) (Fig. 1d). FOXO1 deletion in keratinocytes also affected the for-
mation of collagen matrix. On day 4 the amount of collagen matrix produced was reduced by 40% with a similar 
reduction on day 7 in experimental mice (Fig. 1e), demonstrating the influence of keratinocytes on connective 
tissue wound healing.
Keratinocyte-specific deletion of FOXO1 reduces fibroblast and MSC proliferation. The effect 
of epithelial-specific FOXO1 deletion on myofibroblast was then assessed in vivo by immunofluorescent staining 
for α -smooth muscle actin (α -SMA)20 (Fig. 2a). Myofibroblasts play a crucial role in wound contraction during 
healing. The number of myofibroblasts was reduced 60% by FOXO1 deletion in epithelium (p < 0.05) (Fig. 2b). 
The impact of epithelial-specific FOXO1 deletion on fibroblast numbers was then assessed in vivo in histologic 
sections. Day 4 was chosen since it reflects a time point of robust connective tissue formation. Fibroblast density 
in connective tissue was reduced by 44% (p < 0.05) (Fig. 2b).
The impact of keratinocyte-specific FOXO1 deletion on cells that express MSC markers in connective tissue 
was then measured by assessing the number of CD271 and stem cell antigen1 (Sca1) immunopositive cells21. 
CD271 positive cells were reduced by 55% in keratinocyte-FOXO1 null mice compared to control littermates 
(p < 0.05) (Fig. 2c,d). Sca1 positive cells were reduced by 60% in keratinocyte-FOXO1 null mice (p < 0.05) 
(Fig. 2d). The number of proliferating fibroblasts was measured by assessment of proliferating cell nuclear anti-
gen (PCNA) and were reduced by 42% in keratinocyte-FOXO1 null mice compared to littermate control mice 
(p < 0.05) (Fig. 2e), indicating impaired fibroblast proliferation with epithelial-specific FOXO1 deletion. The num-
ber of proliferating Sca-1 immunopositive cells was reduced by 60% in the connective of keratinocyte-FOXO1 
null mice compared to littermate control (p < 0.05) (Fig. 2e), indicating that FOXO1 expression in keratinocytes 
promotes MSCs proliferation.
The effect of keratinocyte-specific FOXO1 deletion on connective tissue formation in vivo is 
mediated by TGFβ1. Connective tissue growth factor (CTGF also known as CCN2) plays an important 
role in fibroblast behavior during wound healing22 and is induced by transforming growth factor β 1 (TGFβ 1)17. 
Due to the importance of TGFβ 123 and CTGF22 in healing we determined whether FOXO1 deletion in epithelial 
cells affected TGFβ 1 and CTGF expression in the epithelium and connective tissue by standardized quantitative 
immunofluorescence measuring mean fluorescence intensity in each compartment (Fig. 3a). TGFβ 1 expression 
was four-fold higher in the wounded epithelium than connective tissue (Fig. 3b). As expected, expression of 
TGFβ 1 in epithelium was FOXO1 dependent based on our previous results. Surprisingly, TGFβ 1 expression in the 
connective tissue compartment was reduced by ~60% when FOXO1 was absent in epithelia (Fig. 3b), indicating 
that keratinocytes influence TGFβ 1 expression in connective tissue.
In contrast to TGFβ 1, CTGF expression in connective tissue following wounding was 2 fold higher than epi-
thelium (Fig. 3b). CTGF levels in the epithelium of keratinocyte-FOXO1 null mice were reduced by 61% in 
experimental mice. CTGF levels in connective tissue were also dependent upon cutaneous epithelium and were 
reduced by 66% when FOXO1 was ablated in these cells (Fig. 3b). Thus, keratinocytes have a significant role 
in regulating the expression of CTGF in connective tissue. The linkage between keratinocyte-specific FOXO1 
deletion, TGFβ 1 and connective tissue was reinforced by rescue of the deficit in connective tissue formation 
in experimental mice but not control mice treated with exogenous TGFβ 1 (Fig. 3c). Thus, deficiency caused by 
keratinocyte-specific FOXO1 deletion is overcome by addition of TGFβ 1 to wounds while this addition has little 
effect in normal littermate controls, indicating that keratinocyte-produced TGFβ 1 is needed for optimal connec-
tive tissue healing.
The mechanisms through which keratinocytes may regulate fibroblasts and MSCs were examined in vitro. 
FOXO1 silencing in normal human epidermal keratinocytes (NHEK) in vitro significantly reduced TGFβ 1 and 
CTGF mRNA levels (Fig. 3d), consistent with the data obtained from in vivo (Fig. 3b). Moreover, FOXO1 knock-
down in keratinocytes reduced the capacity of epithelial cells to stimulate TGFβ 1 expression in fibroblasts by 
almost 40% and CTGF production by 45% (p < 0.05) (Fig. 3e). Keratinocyte stimulation of TGFβ 1 and CTGF 
expression in fibroblasts was blocked by antibody to TGFβ 1 (p < 0.05) (Fig. 3f). Thus, keratinocytes stimulate 
CTGF expression via TGFβ 1 that is mediated by FOXO1, consistent with reports that fibroblasts are an important 
source of CTGF in dermal wound healing22.
www.nature.com/scientificreports/
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Figure 1. Keratinocyte-specific deletion of FOXO1 impairs connective tissue healing in dermal wounds. 
Dermal wounds were created in experimental mice with keratinocyte-specific FOXO1 deletion (FOXO1 deleted 
in KC) and littermate control (wild-type) mice. (a) FOXO1 expression as measured by fluorescence intensity in 
epithelium and connective tissue in 4 days post-wounding. (b,c) Representative images of Masson’s trichrome 
stained dermal wounds 4 and 7 days post-wounding. Bar represents 500 μ m left panel and 100 μ m right panel. 
Dotted blue lines represent healing edge of the connective tissue and the distance between them represents the 
connective tissue gap. Black arrows point to collagen bundles. (d) Area of granulation tissue formation was 
measured in Masson’s trichrome stained sections for day 4 and day 7 wounds. (e) Newly formed collagen was 
measured in Masson’s trichrome stained sections for day 4 and day 7 wounds. KC, keratinocytes; EP, epidermis; 
CT, connective tissue. n = 5–8 mice per group. *p < 0.05 vs. wild type.
www.nature.com/scientificreports/
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Figure 2. Keratinocyte-specific FOXO1 deletion reduces fibroblast and MSC proliferation. Dermal 
wounds were created in experimental (FOXO1 deleted in KC) and littermate control (wild-type) mice. 
(a) Representative images of α -SMA immunofluorescence with α -SMA specific antibody on day 4 wounds. 
(b) α -SMA immunopositive cells representative of myofibroblasts in newly formed connective tissue (left 
panel). Fibroblasts were identified by their characteristic fusiform-shaped nucleus in hematoxylin and 
eosin stained sections on 4-day wounds (right panel). (c) CD271 immunopositive cells were identified 
by immunofluorescence with CD271-secific antibody 4 days after wounding. (d) CD271 and Sca1 
immunofluorescence analyses of MSCs in the connective tissue of day 4 wounds. (e) PCNA immunopositive 
fibroblastic cells were identified by immunofluorescence with PCNA specific antibody and by characteristic 
appearance of fibroblast nuclei in merged images with DAPI nuclear stain (left panel). Quantification of PCNA 
and Sca1 double immunopositive cells for analyses of proliferating MSCs (right panel). Scale bar, 100 μ m; 
KC, keratinocytes; EP, epidermis; CT, connective tissue. White dashed lines were the boundary between the 
epidermis and the dermis. n = 5–8 mice per group, *p  < 0.05 vs. wild type. Immunofluorescence was negative 
when a matched control antibody was used in lieu of specific antibody.
www.nature.com/scientificreports/
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Figure 3. FOXO1 activity in keratinocytes drives TGFβ1 expression in healing epithelium and connective 
tissue growth factor expression in healing connective tissue. (a) CTGF expression was identified with 
specific CTGF antibody by immunofluorescence in 4-day wounds. Scale bar, 100 μ m. (b) TGFβ 1 and CTGF 
expression was identified with a specific antibody to each by immunofluorescence in day 4 wounds. Expression 
was determined by mean immunofluorescence intensity (MFI). (c) Quantification of new connective tissue 
formation by Masson’s trichrome stain of day 4 wounds with or without TGFβ 1 treatment. (d) qRT-PCR 
analysis of TGFβ 1 and CTGF expression in primary cultures of normal human epidermal keratinocytes 
(NHEK). (e) TGFβ 1 expression was assessed in primary fibroblast cultures with specific antibody by measuring 
mean immunofluorescence intensity and CTGF by ELISA. Fibroblasts were incubated with keratinocyte-
conditioned medium transfected in NHEK cells that had been transfected with FOXO1 siRNA (siFOXO1) 
or scrambled siRNA (siSCR). (f) TGFβ 1 and CTGF immunofluorescence analyses of fibroblasts treated 
with keratinocyte-conditioned medium with TGFβ 1 blocking antibody or matched control IgG. For all 
immunofluorescence experiments, the images were negative when a matched control antibody was used in lieu 
of specific antibody. MFI, mean fluorescence intensity; KC, keratinocytes; EP, epidermis; CT, connective tissues. 
White dashed lines were the boundary between the epidermis and the dermis. n = 5–8 mice per group. *p < 0.05 
vs. matched wild type, **p < 0.05 vs. matched vehicle group, #p < 0.05 vs. scrambled siRNA, &p < 0.05 vs. control 
group, ##p < 0.05 vs. matched IgG control.
www.nature.com/scientificreports/
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Inhibition of TGFβ1 and CTGF blocks fibroblast and MSC proliferation, myofibroblast differen-
tiation, and collagen production in vitro. The role of keratinocytes in regulating fibroblasts and MSCs 
through FOXO1 was explored further. Keratinocytes stimulated fibroblast and MSC proliferation as determined 
by BrdU incorporation and this increase was blocked by FOXO1 knockdown (Fig. 4a,b). The increase stimulated 
by keratinocytes was inhibited by antibody to CTGF (Fig. 4a,b). The combination of TGFβ 1 and CTGF blocking 
antibodies displayed a similar effect as CTGF antibody alone. Since TGFβ 1 stimulates fibroblasts in part through 
CTGF24, the results indicate that CTGF is a critical factor by which keratinocytes regulate fibroblasts through a 
mechanism mediated by FOXO1.
The effect of FOXO1 in modulating keratinocyte regulated MSC differentiation was also investigated. 
Keratinocytes induced a 4-fold increase in MSC differentiation to myofibroblasts determined by α -SMA expres-
sion and 70% of the induction effect was blocked by FOXO1 knockdown (Fig. 4c,e). Moreover, formation of 
myofibroblasts was dependent upon the TGFβ 1/CTGF axis as it was blocked by antibody specific for CTGF or 
TGFβ 1 (p < 0.05) (Fig. 4d,e). Cutaneous epithelial cells also stimulated a 4-fold increase in collagen I production 
examined by enzyme-linked immunosorbent assay (ELISA), which was reduced in half by FOXO1 knockdown 
compared to scrambled siRNA (p < 0.05) and dependent upon TGFβ 1 and CTGF (p < 0.05) (Fig. 4f). These 
studies provide further evidence that FOXO1 regulated TGFβ 1 and CTGF production represents an important 
mechanism through which epithelia modulate connective tissue healing.
Discussion
The cellular and molecular mechanisms that underlie tissue repair are incompletely understood and represent a 
significant health care issue1. Studies presented here establish for the first time in vivo that cutaneous epithelia 
play a key role in the repair of wounded connective tissue and that the transcription factor FOXO1 is essential 
for up-regulating this effect. When FOXO1 is specifically deleted in cutaneous epithelial cells there is a ~40–50% 
reduction in granulation tissue formation and production of extracellular matrix. This is equivalent to the sub-
stantial reduction reported for macrophage deletion and indicates the importance of activating cutaneous epithe-
lial cells to promote connective tissue healing4–6.
It has been postulated that interactions between epidermal keratinocytes and dermal fibroblasts contribute 
to wound healing. The predominant line of thinking has been that cells and growth factors in connective tis-
sue modulate proliferation and migration of keratinocytes to promote re-epithelialization25,26. This is supported 
by evidence that specific deletion of Rac1 in fibroblasts found in connective tissue in vivo negatively impacts 
re-epithelialization27. In contrast, less is known about the control of connective tissue by epithelial cells although 
in vitro studies suggest that factors produced by these cells may affect fibroblast activity15,16. Thus, our in vivo 
results provide the first direct evidence that keratinocytes modulate the repair of connective tissue and sup-
port previous in vitro studies that paracrine factors released by keratinocytes contribute to connective tissue 
healing28,29.
Mesenchymal cells such as fibroblasts are essential to dermal wound healing. In addition to producing con-
nective tissue, fibroblasts provide signals to enhance repair30. The healing of a wound requires the generation of 
well-orchestrated signals that stimulate MSCs and fibroblasts31. Within the wound bed, fibroblasts produce col-
lagen and other extracellular matrix constituents. We found that FOXO1 deletion in epithelium led to impaired 
healing that included decreased formation of new connective tissue. Fibroblast numbers and proliferation were 
both modulated by keratinocytes in a FOXO1 dependent mechanism, consistent with impaired production of 
extracellular matrix. In addition keratinocyte-specific FOXO1 deletion led to reduced MSCs numbers and prolif-
eration, which may contribute to reduced myofibroblast numbers seen in our study, and have secondary effects 
on subsequent healing events32.
TGFβ 1 is an important regulator of connective tissue healing stimulating the production of ECM proteins 
such as collagen and initiating granulation tissue formation33. TGFβ stimulates the expression of CTGF, which is 
thought to be responsible for many of the pro-fibrotic properties of TGFβ , particularly in the promotion of fibro-
blast proliferation and ECM production24,34. CTGF plays a physiological role in early wound healing35. Many dif-
ferent cell types including fibroblasts, epithelial cells, endothelial cells, and vascular smooth muscle cells express 
CTGF36. In wound repair in vivo there is a coordinated up-regulation of TGFβ 1 followed by CTGF expres-
sion22. We found that TGFβ 1 and CTGF expression in both epithelium and connective tissue were decreased by 
keratinocyte-specific deletion of FOXO1. In vitro knockdown of FOXO1 in keratinocytes also reduced TGFβ 1 
and CTGF expression in keratinocytes. Antibody blocking studies demonstrated that TGFβ 1 produced by kerat-
inocytes up-regulates CTGF in fibroblasts, and FOXO1-deletion in keratinocytes results in deficient connective 
tissue formation. In addition, we found that keratinocyte could induce MSCs to differentiate into myofibroblasts 
in vitro, which was blocked by inhibition of TGFβ 1 and/or CTGF. This is consistent with the other report that 
CTGF could direct fibroblast differentiation from human mesenchymal stem/stromal cells in vitro2,34. It is also 
possible that keratinocyte produced CTGF contributes to connective tissue healing.
In summary, we found that keratinocytes played a significant role in regulating connective tissue heal-
ing through a mechanism that was dependent upon FOXO1. Moreover, a key component of this mechanism 
involved TGFβ 1, which is produced in sub-optimal amounts when FOXO1 is deleted in keratinocytes as shown 
by improved healing when TGFβ 1 is applied to experimental mice with keratinocyte-specific FOXO1 deletion 
but not in normal control littermates. Combined with our previous results17, we propose that FOXO1 activation 
induces release of TGFβ 1 by keratinocytes to stimulate re-epithelialization17 and that TGFβ 1 up-regulates CTGF 
expression to promote connective tissue healing by stimulating fibroblasts, myofibroblasts and cells that express 
mesenchymal stem cell markers (see Fig. 5). Our finding indicates that keratinocytes are also important as a 
cellular source of factors that drive connective tissue repair similar to macrophage-derived growth factors that 
stimulate fibroblast proliferation, myofibroblast differentiation and extracellular matrix synthesis4.
www.nature.com/scientificreports/
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Figure 4. Keratinocyte stimulation of fibroblasts and MSCs is dependent on TGFβ1 and CTGF. Primary 
dermal fibroblasts (a,f) and MSCs (b–e) were incubated with conditioned medium collected from keratinocytes 
transfected with FOXO1 or scrambled siRNA, then incubated with TGFβ 1 and/or CTGF blocking antibody 
or matched control IgG. (a,b) DNA synthesis of dermal fibroblasts (a) and MSCs (b) were determined by 
BrdU incorporation. (c) Representative images of α -SMA immunofluorescent staining for MSCs after treated 
with conditioned medium collected from keratinocytes transfected with FOXO1 or scrambled siRNA. 
(d) Representative images of α -SMA immunofluorescent staining for MSCs after treated with keratinocyte 
conditioned medium and TGFβ 1 and/or CTGF blocking antibody. Scale bar, 100 μ m. (e) The quantification of 
α -SMA protein expression by immunofluorescence in MSCs. Data is expressed as mean fluorescence intensity 
(MFI) per number of cells. (f) Collagen I levels in NHDF cells was measured by means of ELISA. *p < 0.05 
compared to siSCR, #p < 0.05 vs. matched IgG group.
www.nature.com/scientificreports/
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Material and Methods
Animal model. Experiments were approved by the University of Pennsylvania Institutional Animal Care and 
Use Committee and all methods were performed in accordance with guidelines and regulations relevant to the 
study. Mice with floxed FOXO1 were generously provided by Ronald A. DePinho (MD Anderson Cancer Center, 
Houston, TX) as previously described37. Mice expressing Cre recombinase [strain Tg (KRT14-cre)1Amc/J] were 
obtained from the Jackson Laboratory (Bar Harbor, ME). Keratinocyte-specific FOXO1 deletion was obtained by 
crossing the above two mentioned mice to generate experimental (FOXO1 deleted in KC) and control littermates. 
All the experiments were performed with adult mice age of 16–20 weeks.
Skin wounding experiment. Mice were anesthetized by i.p. administration of ketamine (80 mg/kg) and 
xylazine (5 mg/kg). The scalp was shaved and cleansed with isopropyl alcohol and prepared for surgery. Two exci-
sional wounds were made with a 2mm sterile biopsy punch in the scalp to create a circular full-thickness wounds 
as described previously38. Wounds were harvested on days 4 and 7 post-wounding. Wound healing process was 
assessed by quantification of the calibrated digital photographs. The wound areas were calculated from the pho-
tographs using Nikon NIS-elements D image analysis software (Nikon). For TGFβ 1 treatment experiment, 100ng 
of recombinant TGFβ 1 (PeproTech) in 20 μ l of 3% methylcellulose vehicle or vehicle alone was topically applied 
to the wounds every other day from the time of wounding. In most in vivo experiments, 6–8 mice were examined 
per group.
H&E staining and Masson’s trichrome staining. The scalp and attached calvarial bone were fixed in 
4% paraformaldehyde overnight and decalcified in 10% EDTA solution. Five-micrometer sections were stained 
using hematoxylin & eosin (H&E) for microscopic evaluation of the epithelial gap and the granulation tissue gap 
using Nikon NIS-elements image analysis software (Nikon) at the center of each lesion. The connective tissue gap 
was measured by drawing parallel lines along the edge of the connective tissue adjacent to the open wound and 
the distance between them was measured. Granulation tissue formation was measured in Masson’s trichrome 
stained sections as highly cellular tissue which stained red. Recently formed collagen matrix stains light blue 
compared to dark blue mature collagen matrix. The wound edges were determined by use of histologic landmarks 
including the position of hair follicles and thickened epithelium and the floor of the wound was bordered by the 
osseous floor or muscle bundles. Newly formed collagen matrix in the wound area was measured with Nikon 
NIS-elements image analysis software. Collagen matrix was identified by its characteristic color in Masson’s tri-
chrome stained sections.
Immunofluorescent staining in vivo. Immunofluorescent staining was performed on paraffin sec-
tions that were fixed with 4% paraformaldehyde sectioned at 4 microns. After blocking with nonspecific 
binding blocking buffer (Millipore), tissue sections were incubated with the appropriate primary antibodies 
followed by biotinylated secondary antibody (Vector Laboratories). Sections were subsequently incubated with 
avidin-biotin-peroxidase enzyme complex (Vector Laboratories) and followed by tyramide signal amplification 
(PerkinElmer) to enhance the fluorescent signal. Nuclei were stained with DAPI. Primary antibodies used were 
Sca1 (Abcam), CD271 (Abcam), CTGF (Santa Cruz Biotechnology Inc.), TGFβ 1 (Abcam) and α -SMA (Abcam). 
Images were captured using a fluorescence microscope (ECLIPSE 90i, Nikon). Images for control antibodies 
gave negative immunostaining. Nikon NIS Elements AR image analysis software (Nikon) was used to do image 
analysis. Percent positive cells were calculated from the number of immunopositive cells divided by the number 
of DAPI positive cells. To examine expression levels mean fluorescence intensity was measured. In each case, a 
Figure 5. FOXO1 organizes keratinocyte activity to promote connective tissue healing. During wound 
healing FOXO1 binds to the TGFβ 1 promoter in keratinocytes to up-regulate TGFβ 1 expression, which 
promotes connective tissue wound healing directly and also induces CTGF production. TGFβ 1 and CTGF 
stimulate differentiation of myofibroblasts and connective tissue formation. In addition, TGFβ 1 stimulates 
keratinocyte migration to enhance re-epithelialization. Leukocytes, particularly macrophages also produce 
growth factors to enhance healing.
www.nature.com/scientificreports/
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standardized region of interest was defined in each specimen and was of similar size. After the region of interest 
was selected the exposure time was set to obtain results in the linear range.
Cell culture. Primary normal human epidermal keratinocytes (NHEK) were purchased from Lonza and cul-
tured in KGM-2 growth medium in the presence of human keratinocyte growth supplements (Lonza) and anti-
biotics (Life Technologies). For experiments, insulin was excluded from the culture media to prevent inactivation 
of FOXO1. NHDFs were maintained in DMEM medium containing 10% fetal bovine serum (FBS) (Gibco, life 
technologies), while hBMSCs were maintained in α -MEM medium supplemented with 10% FBS. All the cell 
cultures were maintained in 5% CO2/air and used between passages P1–P4.
Conditioned Media Experiments. The effect of keratinocyte-conditioned media (CM) on TGFβ 1 and 
CTGF expression in normal human dermal fibroblasts (NHDF) was performed as follows. In cases where CM was 
collected from transfected cells, conditioned media was collected from transfected keratinocytes 24 hours after 
transfection with FOXO1 siRNA or scrambled control siRNA (Dharmacon) using GenMute siRNA Transfection 
Reagent (SignaGen Labs). Cells were incubated with 5–10 nM siRNA with transfection reagent for six hours and 
transferred to standard medium for 16 hours. Cells were transferred to fresh media for the collection of condi-
tioned media. To assess the impact of conditioned media on fibroblasts or human bone marrow-derived mesen-
chymal stem cells (hBMSCs) the conditioned media was diluted 1:1 with α -MEM medium supplemented with 1% 
FBS. Therefore, the fibroblasts were incubated in low-serum (total 0.5% FBS) when stimulated with keratinocyte 
conditioned media. For antibody neutralization studies, anti-TGFβ 139 (10 μ g/ml, R&D Systems) or anti-CTGF40 
blocking antibody (10 μ g/ml, Santa Cruz) was added 1 hour prior to incubation of keratinocyte-conditioned 
media with NHDF or hBMSCs for 3 days.
Immunofluorescent staining in vitro. Cells were fixed briefly with 10% formalin, permeabilized with 
0.5% Triton X-100 and incubated overnight at 4 °C with primary antibodies to TGFβ 1 (Abcam), CTGF (Santa 
Cruz), α -SMA (Abcam) or an equal amount of matched negative control IgG, then with the corresponding sec-
ondary antibody. Nuclei were stained with DAPI. Images were captured with a fluorescence microscope (Nikon) 
and the mean fluorescence intensity (MFI) was determined using NIS-Elements AR software (Nikon).
BrdU incorporation Assay. The effect of keratinocyte-CM on the proliferation of fibroblasts and MSCs 
were determined with a BrdU Cell Proliferation Assay Kit (Cell Signaling Technology). CM were then collected 
from keratinocytes transfected with FOXO1 siRNA or scrambled control siRNA, and incubated with fibro-
blasts or MSCs in 96-well plates with/without TGFβ 1 antibody (R&D Systems) or/and CTGF blocking antibody 
(Santa Cruz) for 72 hours, and incubated with 10 μ M BrdU for 6 hours. Cells were fixed with cold methanol and 
incubated with anti-BrdU antibody. BrdU incorporation was determined by measuring absorbance at 450 nm. 
Experiments were repeated at least three times.
Real-time PCR. Total RNA was isolated from NHEK cells transfected with FOXO1 or scrambled siRNA 
using an RNeasy kit (Qiagen). After reverse transcription (Applied Biosystems), real-time quantitative PCR 
(qPCR) for was performed with Taqman system (Roche Diagnostics). Results were normalized with values 
obtained from ribosomal protein RPL32, a ribosomal protein. Experiments were repeated three to four times.
ELISA. CTGF levels in media from fibroblasts treated with keratinocyte-CM were determined by measuring 
the levels of CTGF in media using specific ELISA kit (PeproTech). Collagen levels in fibroblasts were measured as 
follows. Fibroblasts were first starved in 0.1% FBS for 24 hours, then treated with keratinocyte-CM with/without 
TGFβ 1 (R&D Systems) or/and CTGF blocking antibody (Santa Cruz) for 72 hours. Supernatant was collected to 
measure collagen by ELISA (Biomatik).
Statistics. All data are reported as the mean ± standard deviation. Group mean values were compared, as 
appropriate, by Student’s two-tailed t-test or one-way ANOVA with Scheffe’s post-hoc test. A p-value < 0.05 was 
considered significant.
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